Lisinopril/Hydrochlorothiazide fixed-dose combination tablet (20 mg/25 mg)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lisinopril/Hydrochlorothiazide fixed-dose combination tablet (20 mg/25 mg), covering 2013-04-10 to 2013-04-10. Get the full timeline:
Most recent: Clinical Trial Update: Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fed Conditions [Phase 1]